Jennie P. Mather

Dr. JENNIE P. MATHER, Founder, President and CEO of Raven
Biotechnologies, Inc., has over 30 years of experience in cell
culture and cell biology research. She obtained her PhD and did
postdoctoral work at the University of California, San Diego.
After a year as an NIH/INSERM Exchange Scientist in Lyon, France,
Dr. Mather joined the faculty of The Rockefeller University. In
1984 she joined Genentech, Inc., as a Senior Scientist in Process
Sciences and was promoted to Staff Scientist in 1988. She was
involved in designing cell culture production processes for four
currently marketed recombinant protein products. In 1994, she and
her group moved to the research division of Genentech where she
initiated discovery research projects in the areas of
neurobiology, endocrinology and cancer biology and contributed to
a genomics screening effort. While at Genentech, Dr. Mather was a
member of more than 12 project teams. This has given her exposure
to most aspects of biotechnology product development, from the
initial assessment of ideas, to forming and leading a team
through the research and early development phases of a new drug.
In January 1999, Dr. Mather left Genentech to found Raven
Biotechnologies, a company whose mission is the rapid and focused
discovery of drug targets and therapeutics using an integrated
cell biology-based approach to drug discovery. Dr Mather has been
named inventor on more than 25 patents and has authored or edited
five books, including Introduction to Cell and Tissue Culture,
and more than 150 publications. As Founder, President and CEO of
Raven Biotechnologies, she has raised $66 million and grown Raven
from its inception to its current size of more than 50 people. In
2002, Dr. Mather was named one of the top 10 innovators by Red
Herring Magazine.